ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVS Novartis AG

96.00
0.12 (0.13%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,524,700
Bid Price
Ask Price
News -
Share Name Share Symbol Market Stock Type
Novartis AG NVS NYSE Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.12 0.13% 96.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
96.31 96.15 97.20 96.73 95.88
Trades Shares Traded VWAP Financial Volume Average Volume
22,284 1,524,700  96.77  147,543,960 -
Last Trade Type Quantity Price Currency
18:12:41 2  96.73 USD

Novartis (NVS) Options Flow Summary

Overall Flow

Bullish

Net Premium

58k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

33.33%

Sweeps Ratio

0.00%

Novartis AG Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
197.27B 2.04B - 54.11B 14.85B 7.27 13.28
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Novartis

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVS Message Board. Create One! See More Posts on NVS Message Board See More Message Board Posts

NVS Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.

Your Recent History

Delayed Upgrade Clock